Oaktree Acquisition Corp. III Life Sciences is a blank check company formed to complete a business combination with one or more target companies. It seeks opportunities in the biopharmaceutical, medical device, diagnostics, and specialized healthcare services sectors in North America and Europe. Until a merger occurs, the company has no operating business or revenue.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 0 | — | 1.7 | — |
| Q2 2025 | 0 | — | 1.9 | — |
| Q3 2025 | 0 | — | 2 | — |
| Q4 2025 | 0 | — | 1.8 | — |
| Q1 2026 | 0 | — | 1.4 | -16% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Exascale Labs Holdings Inc. Class A Common Stock (XLAB), Soluna Holdings, Inc. (SLNH), Newbury Street II Acquisition Corp (NTWO), AIAI Holdings Corporation (AIAI), Asure Software, Inc. (ASUR), Better Home & Finance Holding Company (BETR)